MIKA Pharma GmbH was established for the development and production of primarily dermal, transdermal, and buccal application systems for pharmaceuticals on the basis of sprayable liposomes, pre-liposomal solutions and proprietary micellar nano-solutions. The overall MIKA Pharma GmbH portfolio contains products and advanced projects in various indication fields, e.g. sports injuries, rheumatic disorders, pain, superficial thrombophlebitis, cough, fungal infections, various skin disorders, to mention just a few.